China NMPA Approval Tracker
China Deals Tracker
China Biotech Fundraising Tracker
Chinese regulators clarify factors for picking drugs for reimbursements
Chinese regulators have shared their considerations on selecting drugs for inclusion in state medical insurance, which should give drugmakers food for thought in terms of their strategy.
Copyright © 2016-2022 PharmaDJ .All Rights Reserved. Suggestions and feedback: